Concert Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Concert Wealth Management's ABBV Position: Q3 2017 in Review
Concert Wealth Management sold out of AbbVie (ABBV) in Q3 2017, closing a stake of 17,870 shares — an estimated $1.3M sold.
Concert Wealth Management first reported a position in ABBV in Q2 2013 and held it in 17 quarters. The position peaked at $4.04M in Q3 2016. 1,797 funds tracked by Wall St. Rank hold ABBV as of Q3 2017.
- Concert Wealth Management reported no remaining AbbVie position as of Q3 2017 after selling out during the quarter.
- Concert Wealth Management sold 17,870 AbbVie shares in Q3 2017, an estimated $1.3M.
- Concert Wealth Management first reported a position in AbbVie in Q2 2013 and held it in 17 quarters.
- Concert Wealth Management's AbbVie position peaked at $4.04M in Q3 2016.
- 1,797 funds tracked by Wall St. Rank held AbbVie as of Q3 2017.
Based on Concert Wealth Management's 13F filing for Q3 2017, filed 14 Nov 2017.